e13154 Background: Many people harbor pulmonary nodules. Such nodules can be detected by low-dose computed tomography (LDCT) during regular physical examinations. If a pulmonary nodule is small (i.e. < 10mm), it is very difficult to diagnose whether it is benign or malignant using CT images alone. To address this problem, we developed a method based on liquid biopsy and deep learning to improve diagnostic accuracy of pulmonary nodules. Methods: Thirty-eight patientsharboring one or more small pulmonary nodules were enrolled in this study. Twenty-nine patients were diagnosed as having cancer (stage I = 21, stage II = 1, stage III = 3, stage IV = 4) using tissue biopsy, while the other 9 patients were diagnosed as having benign tumors or lung diseases other than cancer. For each patient, a blood sample was obtained prior to biopsy, and the cell free DNA (cfDNA) was sequenced using a 451-gene panel to a depth of 20,000×. The unique molecular identifiers (UMI) technique was applied to reduce false positives. Seventeen patients also had full-resolution CT images available. A deep learning system primarily based on deep convolutional neural networks (CNN) was used to analyze these CT images. Results: Sequence analysis of blood samples revealed that 75.8% (22/29) of cancer patients had detectable cancer related mutations, and only 1 of 9 (11.1%) non-cancer patient was found to carry a TP53 mutation. The most frequent mutations seen in cancer patients involved genes TP53 (N = 11), EGFR (N = 7), and KRAS (N = 3) with mutant allele fractions varying from 0.08% to 74.77%. Deep learning analysis of the 17 available CT images correctly identified cancers in 88.2% (15/17) of patients. However, by combining the liquid biopsy and image analysis results, all 17 patients were correctly diagnosed. Conclusions: Deep learning-based analysis of CT images can be applied to early diagnosis of lung cancers; but the accuracy of image analysis, when used alone, is only moderate. Diagnostic accuracy can be greatly improved using liquid biopsy as an auxiliary method in patients with pulmonary nodules.